Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引:67
作者
Larkin, Howard D. D.
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期
关键词
D O I
10.1001/jama.2022.24490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
[21]   Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease [J].
Park, Juliane ;
Simpson, Carson ;
Patel, Katie .
ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) :1045-1053
[22]   Lecanemab for Alzheimer's disease [J].
Walsh, Sebastian ;
Merrick, Richard ;
Richard, Edo ;
Nurock, Shirley ;
Brayne, Carol .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[23]   Lecanemab for Alzheimer's disease [J].
Walsh, Sebastian ;
Merrick, Richard ;
Richard, Edo ;
Nurock, Shirley ;
Brayne, Carol .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[24]   Ceritinib Gains FDA Approval for Lung Cancer [J].
不详 .
CANCER DISCOVERY, 2014, 4 (07) :753-754
[25]   Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab [J].
Rabinovici, Gil D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (09) :771-774
[26]   US FDA defends approval of Alzheimer's disease drug [J].
Jaffe, Susan .
LANCET, 2021, 398 (10294) :12-12
[27]   Surgical sealant gains FDA approval to market [J].
不详 .
ADHESIVES AGE, 2001, 44 (09) :7-7
[28]   FDA issues Aricept® approval for severe Alzheimer's disease [J].
不详 .
PSYCHOPHARMAKOTHERAPIE, 2007, 14 (01) :X-X
[29]   Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective [J].
Dunn, Billy ;
Stein, Peter ;
Cavazzoni, Patrizia .
JAMA INTERNAL MEDICINE, 2021, 181 (10) :1276-1278
[30]   Chocolate ballon catheter gains FDA approval [J].
Fitzpatrick, Sean .
EXPERT REVIEW OF MEDICAL DEVICES, 2012, 9 (02) :103-103